Literature DB >> 19176998

Mdm2 and PCAF increase Chk2 ubiquitination and degradation independently of their intrinsic E3 ligase activities.

Elizabeth M Kass1, Masha V Poyurovsky, Yan Zhu, Carol Prives.   

Abstract

We have previously shown that Chk2 stability, which is increased after DNA damage in some cells, is regulated in part through phosphorylation at S456 and that a mutant Chk2 (S456A) is hyperubiquitinated and turned over more rapidly than wild-type Chk2.(1) Here we show that the S456A mutant preferentially binds to Mdm2 compared to wild-type Chk2 and downregulation of Mdm2 with siRNA can rescue the observed destabilization of S456A Chk2 following DNA damage. Ubiquitination of wild-type Chk2 is increased by co-expression of Mdm2, and increasing amounts of Mdm2 enhance degradation of both wild-type and mutant S456A Chk2. Surprisingly, however, an E3 ligase defective version of Mdm2 (DeltaC7) also increases ubiquitination and degradation of Chk2 when transfected into cells, suggesting that the ability of Mdm2 to affect Chk2 turnover is independent of its intrinsic E3 ligase function. Recently the acetyltransferase PCAF was shown to have intrinsic E3 ligase activity against itself and Mdm2. We found that PCAF interacts with both Mdm2 and Chk2 and that PCAF increases Chk2 ubiquitination and degradation. Interestingly as well, a PCAF deletion mutant that lacks E3 ligase activity towards Mdm2 also enhances Chk2 degradation. We hypothesize that Mdm2 and PCAF may function as part of a multi-subunit E3 complex in their regulation of Chk2 turnover.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176998     DOI: 10.4161/cc.8.3.7624

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

1.  PCAF acts as a gastric cancer suppressor through a novel PCAF-p16-CDK4 axis.

Authors:  Hong-Jun Fei; Li-Dong Zu; Jun Wu; Xiao-Shu Jiang; Jing-Long Wang; Y Eugene Chin; Guo-Hui Fu
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  MPP8 and SIRT1 crosstalk in E-cadherin gene silencing and epithelial-mesenchymal transition.

Authors:  Lidong Sun; Kenji Kokura; Victoria Izumi; John M Koomen; Edward Seto; Jiandong Chen; Jia Fang
Journal:  EMBO Rep       Date:  2015-04-13       Impact factor: 8.807

3.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

4.  Multiple faces of the SAGA complex.

Authors:  Evangelia Koutelou; Calley L Hirsch; Sharon Y R Dent
Journal:  Curr Opin Cell Biol       Date:  2010-04-02       Impact factor: 8.382

5.  The Rb binding domain of HPV31 E7 is required to maintain high levels of DNA repair factors in infected cells.

Authors:  Bryan A Johnson; Heather L Aloor; Cary A Moody
Journal:  Virology       Date:  2016-10-19       Impact factor: 3.616

6.  The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover.

Authors:  M Bohgaki; A Hakem; M J Halaby; T Bohgaki; Q Li; P A Bissey; J Shloush; T Kislinger; O Sanchez; Y Sheng; R Hakem
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

7.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03

8.  Protecting the genome from mdm2 and mdmx.

Authors:  Alexia N Melo; Christine M Eischen
Journal:  Genes Cancer       Date:  2012-03

Review 9.  Pirh2: an E3 ligase with central roles in the regulation of cell cycle, DNA damage response, and differentiation.

Authors:  Marie-jo Halaby; Razqallah Hakem; Anne Hakem
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

10.  E2F1-dependent oncogenic addiction of melanoma cells to MDM2.

Authors:  M Verhaegen; A Checinska; M B Riblett; S Wang; M S Soengas
Journal:  Oncogene       Date:  2011-07-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.